Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) patients are at a substantial risk for developing cardiovascular disease (CVD). High-density lipoprotein (HDL) is well known to have protective effects against the development of atherosclerotic CVD. One of the major antiatherogenic effects of HD...

Descripción completa

Detalles Bibliográficos
Autores principales: Karami, Sara, Poustchi, Hossein, Sarmadi, Negar, Radmard, Amir Reza, Ali Yari, Fatemeh, Pakdel, Abbas, Shabani, Parisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549143/
https://www.ncbi.nlm.nih.gov/pubmed/34702329
http://dx.doi.org/10.1186/s13098-021-00741-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549143/
https://www.ncbi.nlm.nih.gov/pubmed/34702329
http://dx.doi.org/10.1186/s13098-021-00741-5

Ejemplares similares